Gotowe bibliografie tematyczne / Squamous cell carcinoma

Gotowa bibliografia na temat „Squamous cell carcinoma”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 28 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Squamous cell carcinoma”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Squamous cell carcinoma"

1

Hoy, Nathan, Joyce Wong, Muhammad Mahmood i Alain Brassard. "Basaloid Squamous Cell Carcinoma of the Nasal Septum Presenting as a Primary Cutaneous Lesion". Journal of Cutaneous Medicine and Surgery 16, nr 5 (wrzesień 2012): 375–77. http://dx.doi.org/10.1177/120347541201600520.

Pełny tekst źródła
Streszczenie:
Background: Basaloid squamous cell carcinoma is a rare aggressive variant of squamous cell carcinoma, with a predilection for the head and neck region. There are only two case reports in the literature documenting a nasal cavity squamous cell carcinoma presenting as a primary cutaneous lesion. Objective: We report a rare case of nasal cavity basaloid squamous cell carcinoma presenting initially as a nasal bridge mass. Two initial biopsies revealed features consistent with basal cell carcinoma and basosquamous cell carcinoma, respectively. Result: Final surgical pathology showed extensive invasive squamous cell carcinoma with basaloid differentiation arising from the nasal septal mucosa with extension to the overlying skin. The clinicopathologic features were interpreted as basaloid squamous cell carcinoma. Conclusion: We discuss the difficulties in pathologic diagnosis of this condition given its varied phenotypical expression. As well, this case emphasizes the necessity for diagnostic vigilance when assessing a primary cutaneous lesion as it may be a rare presentation of an underlying malignancy extending to the skin. Contexte: Le carcinome squameux basaloïde est une variante rare et très maligne du carcinome squameux, qui touche le plus souvent la tête et le cou. La documentation médicale ne compte que deux exposés de cas sur le carcinome squameux de la cavité nasale se présentant sous forme de lésion cutanée primitive. Objectif: Nous faisons état ici d'un rare cas de carcinome squameux basaloïde de la cavité nasale, se présentant au départ comme une masse dans la voûte des fosses nasales. Deux biopsies ont été pratiquées au départ, et les résultats se sont montrés compatibles avec les caractéristiques du carcinome basocellulaire et du carcinome basospinocellulaire, respectivement. Résultat: L'examen histopathologique définitif de la pièce opératoire a révélé la présence d'un carcinome squameux invasif, étendu, accompagnée d'une différenciation basaloïde prenant naissance dans la muqueuse de la cloison nasale et se prolongeant jusqu'à la peau sus-jacente. Les manifestations clinicopathologiques laissaient croire à un carcinome squameux basaloïde. Conclusion: Il sera question ici des difficultés que pose le diagnostic histopathologique de cette affection compte tenu de son expression phénotypique variée. De plus, le cas met en évidence la nécessité de faire preuve de vigilance dans l'établissement du diagnostic lorsqu'on évalue des lésions cutanées primitives étant donné que celles-ci peuvent être une manifestation rare d'une tumeur maligne sous-jacente, qui s'étend jusqu'à la peau.
Style APA, Harvard, Vancouver, ISO itp.
2

Bajaj, Anubha. "Vortex and Crater-Squamous Cell Carcinoma Lung". Journal of Medical Case Studies 1, nr 1 (2023): 1–3. http://dx.doi.org/10.23880/jmcs-16000108.

Pełny tekst źródła
Streszczenie:
Squamous cell carcinoma lung manifests as a malignant tumefaction emerging from epithelial cells demonstrating squamous differentiation. Squamous epithelial differentiation within the neoplasm is represented by morphological features as variable proportion of intercellular bridges, focal intracellular or extracellular keratinization and configuration of keratin pearls, cogent immunohistochemistry may be advantageously applied for diagnostic confirmation. Squamous cell carcinoma lung may appear as keratinizing or non-keratinizing neoplasm. Additionally, diverse subtypes as solid, cystic, papillary, pseudo-glandular, alveolarfilling or sarcomatoid with spindle shaped cells may be observed.
Style APA, Harvard, Vancouver, ISO itp.
3

Diah Ari Bestari, Made, i R. Yully Prapyatiningsih. "Squamous Cell Carcinoma Sinonasal: A Case Report". International Journal of Science and Research (IJSR) 13, nr 6 (5.06.2024): 797–801. http://dx.doi.org/10.21275/sr24608141101.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Terry, Jefferson, Alessandro De Luca, Samuel Leung, Graeme Peacock, Yuzhuo Wang, W. Mark Elliot i David Huntsman. "Immunohistochemical Expression of Neurotrophic Tyrosine Kinase Receptors 1 and 2 in Lung Carcinoma: Potential Discriminators Between Squamous and Nonsquamous Subtypes". Archives of Pathology & Laboratory Medicine 135, nr 4 (1.04.2011): 433–39. http://dx.doi.org/10.5858/2010-0038-oa.1.

Pełny tekst źródła
Streszczenie:
Abstract Context.—The neurotrophic tyrosine kinase receptors NTRK1 and NTRK2 have been implicated in the pathogenesis of lung carcinomas. NTRK receptor expression has been reported in lung carcinomas; however, the clinical utility of immunohistochemical expression of these receptors is unclear. Objective.—To compare the immunohistochemical expression profiles of NTRK1 and NTRK2 in various histologic subtypes of lung carcinomas and correlate with patient outcome. Design.—Six hundred eighty-six unique lung cancer cases (including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, small cell carcinoma, and carcinoid tumor) with clinical outcome data in tissue microarray format were immunohistochemically stained for NTRK1 and NTRK2 using commercially available antibodies, automated immunostaining, and standard protocols. Results.—Expression of both NTRK1 and NTRK2 correlates strongly with squamous histology. NTRK1 and NTRK2 are highly specific markers (1: 92.8%, 2: 96.4%) of squamous lung carcinoma when compared with the other carcinoma subtypes, including adenocarcinoma. Positive NTRK2 staining in squamous carcinoma correlates with improved disease-specific survival (P < .001) and overall survival (P = .047). Conclusions.—NTRK1 and NTRK2 are potentially useful immunohistochemical markers that may be particularly helpful in separating squamous cell carcinoma from adenocarcinoma.
Style APA, Harvard, Vancouver, ISO itp.
5

Chen, Hao, Liru Tian, Jiahong Chen, Peng Sun, Runkun Han, Xingping Wu i Shuqin Dai. "Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma". Cancer Control 27, nr 1 (1.01.2020): 107327482098302. http://dx.doi.org/10.1177/1073274820983025.

Pełny tekst źródła
Streszczenie:
Background: This study compared the analytical performance of the Elecsys 602 (Roche Diagnostics) system with the I2000 (Abbott laboratories) system for the quantitative measurement of squamous cell carcinoma antigen (SCCA) to assess its role as an indicator in pan squamous cell carcinoma. Methods: 435 serum samples included pan squamous cell cancer group (n = 318) and healthy subjects (n = 52) and non-squamous cell group (n = 41) and benign diseases group (n = 24) were measured by 2 systems and compared. Results: The within-run precision coefficient of variation (CV) for Abbott and Roche systems were 3.34-4.88% and 0.95 -1.96%, and the total precision CV were 2.89-9.48% and 3.97-5.38%, respectively. Good correlation was showed in Abbott and Roche systems (slopes = 0.749, r = 0.9658). Serum SCCA in the groups of nasopharyngeal carcinomas, lung squamous cell carcinoma, esophageal squamous cell carcinoma, bladder cancer and cervical squamous cell carcinoma under the curve area (AUC) was more than 0.5, while the AUC in the non- nasopharyngeal carcinomas head and neck squamous cell carcinoma was less than 0.5. The AUC of 2 systems was statistically different in lung squamous cell carcinoma and nasopharyngeal carcinomas (P < 0.05). The levels of SCCA of 2 systems were similarities in esophageal squamous cell carcinoma(stage IV vs. stage 0a-II)and bladder cancer(stage I vs. stage Oa)and cervical squamous cell carcinoma(stage IIB-III vs. stage I-IIA), which advanced stage had higher level of SCCA than early stage. But the SCCA levels of 2 systems were inconsistent in bladder cancer (stage II-IV vs. stage Oa in Abbott), head and neck squamous cell carcinoma (stage IV vs. stage Oa-I in the Roche) and lung squamous cell carcinoma (stage III vs. stage I-II in the Roche). (P < 0.05) Conclusions: 2 systems correlated well in SCCA detection of squamous cell carcinoma, but there were individual differences. Serum SCCA may also contribute to the diagnosis of bladder cancer.
Style APA, Harvard, Vancouver, ISO itp.
6

Milroy, C. M., P. J. Robinson i H. R. Grant. "Primary composite squamous cell carcinoma and large cell neuroendocrine carcinoma of the hypopharynx". Journal of Laryngology & Otology 103, nr 11 (listopad 1989): 1093–96. http://dx.doi.org/10.1017/s0022215100111107.

Pełny tekst źródła
Streszczenie:
AbstractNeuroendocrine carcinomas are rare neoplasms of the larynx and hypopharynx. Tumours composed of both neuroendocrine and Squamous cell elements are very rare. We report a case of a primary hypopharyngeal carcinoma composed of both squamous cell and large cell neuroendocrine carcinoma and discuss the treatment of this patient and management of neuroendocrine carcinomas of the larynx and hypopharynx.
Style APA, Harvard, Vancouver, ISO itp.
7

Gaddikeri1, Kavitha, i Deepak D. Bhorgonde2. "Assessment of role of mast cells in oral squamous cell carcinoma". Asian Pacific Journal of Health Sciences 3, Supplimentary 2016 (31.12.2016): 63–66. http://dx.doi.org/10.21276/apjhs.2016.3.4s.9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Cuevas, Pedro, Sueiro A, Angulo J, Asin E i Gim G. "Treatment of squamous lung cell carcinoma with inhaled etamsylate". International Journal of Medical Reviews and Case Reports 4, Reports in Clinical Medicine and (2020): 120. http://dx.doi.org/10.5455/ijmrcr.treatment-squamous-lung-cell-carcinoma.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ko, Christine J., G. Peter Sarantopoulos, Sunita Bhuta i Scott W. Binder. "Scalp Paraffinoma Underlying Squamous Cell Carcinoma". Archives of Pathology & Laboratory Medicine 128, nr 10 (1.10.2004): 1171–72. http://dx.doi.org/10.5858/2004-128-1171-spuscc.

Pełny tekst źródła
Streszczenie:
Abstract We report the case of an 84-year-old man with multiple squamous cell carcinomas located on his bald scalp, arising in association with underlying paraffinoma. Histologically, poorly differentiated, acantholytic squamous cell carcinomas were located above characteristic pseudocystic spaces. Carcinomas have been reported in association with penile and breast paraffinomas, but we are unaware of any reports of squamous cell carcinoma arising over a scalp paraffinoma.
Style APA, Harvard, Vancouver, ISO itp.
10

Shah, Akeesha A., Susanne K. Jeffus i Edward B. Stelow. "Squamous Cell Carcinoma Variants of the Upper Aerodigestive Tract: A Comprehensive Review With a Focus on Genetic Alterations". Archives of Pathology & Laboratory Medicine 138, nr 6 (1.06.2014): 731–44. http://dx.doi.org/10.5858/arpa.2013-0070-ra.

Pełny tekst źródła
Streszczenie:
Context.— Squamous cell carcinoma of the upper aerodigestive tract is a heterogenous entity. Although conventional squamous cell carcinomas are easily recognized, the morphologic variants of squamous cell carcinoma can present a diagnostic challenge. Familiarity with these variants is necessary because many are associated with unique risk factors and are characterized by specific molecular alterations (eg, nuclear protein in testis midline carcinomas). Perhaps the most important distinction is in identifying viral-related from nonviral-related carcinomas. The accurate diagnosis of these variants is necessary for prognostic and therapeutic reasons. Objectives.— To provide a clinicopathologic overview and summary of the molecular alterations of the common squamous cell carcinoma variants, including verrucous, spindle cell, acantholytic, adenosquamous, basaloid, and papillary squamous cell carcinoma, as well as nuclear protein in testis midline carcinoma, and to discuss the distinguishing features of human papillomavirus- and Epstein-Barr virus-related squamous cell carcinomas. Data Sources.— Published peer-reviewed literature. Conclusions.— Familiarity with squamous cell carcinoma variants is essential for proper diagnosis and to guide appropriate clinical management. Further insight into the molecular alterations underlying those variants may lead to alterations in existing treatment approaches and to evolution of novel treatment modalities.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Squamous cell carcinoma"

1

Murphy, Justin Thomas. "Radioresistance in oral squamous cell carcinoma". Thesis, University of Hull, 2008. http://hydra.hull.ac.uk/resources/hull:770.

Pełny tekst źródła
Streszczenie:
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common cancer accounting for approximately 6% of all cancers worldwide. However the distribution across the globe varies considerably. The majority of small tumours of the oral cavity and upper aerodigestive tract, in the absence of metastatic disease, can be successfully treated with surgery or radiotherapy. Despite this most small tumours of the oral cavity are now treated with surgery as the primary treatment modality with radiotherapy being reserved for adjuvant therapy, palliation or in patients unfit for surgery. Radiotherapy is also used in cases where there is doubt about the completeness of resection and where adverse histological characteristics are present. Unfortunately, on average about 10% of tumours treated in this way are resistant to radiotherapy, developing tumour recurrence within the original radiotherapy field during the ensuing 12 months. Patients with radioresistant tumours are not only receiving a therapy that is unnecessary but are also being put at risk of potentially serious complications, e.g. osteoradionecrosis of the cervical spine. The primary aim of this thesis was to investigate the mechanism of radioresistance and create an in vitro model of a radioresistant oral squamous cell carcinoma. The methods of cell culture, microarray analysis and immunohistochemistry were employed to this end. Two novel radioresistant cell lines, PE-CAPJ41RR and PE-CAPJ49RR, were created and a number of targets identified using microarray analysis. Immunohistochemistry was used to investigate the relationship EGFR, Bcl-2, BAX and COX-2 had with radiotherapy response.
Style APA, Harvard, Vancouver, ISO itp.
2

Hui, King-cheung, i 許景祥. "Biomarkers for esophageal squamous cell carcinoma". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B41634020.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Hui, King-cheung. "Biomarkers for esophageal squamous cell carcinoma". Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B41634020.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Law, Bic-fai Fian. "Molecular genetics of esophageal squamous cell carcinoma". Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B3660446X.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Mallipeddi, Rajeev. "Understanding squamous cell carcinoma in epidermolysis bullosa". Thesis, King's College London (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.416097.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ash, Cecil Samuel. "Mandibular invasion in oral squamous cell carcinoma". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq23202.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Sun, Li. "Molecular cytogenetics of oral squamous cell carcinoma". Click to view the E-thesis via HKUTO, 2002. http://sunzi.lib.hku.hk/HKUTO/record/B38627887.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Lim, Kue Peng. "Fibroblasts in human oral squamous cell carcinoma". Thesis, University of Bristol, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.503859.

Pełny tekst źródła
Streszczenie:
The tumour microenvironment is known to play an important role in tumour development and progression. The diversity and role of stromal fibroblasts in human oral cancer, however, is unknown. In this study, fibroblasts were oral cancer, however, is unknown. In this study, fibroblasts were isolated from cultures of normal oral mucosa, oral epithelial dysplasia and mortal and immortal oral carcinomas, the latter malignancy being genetically unstable. Using global gene expression profiling, we demonstrated that fibroblasts clustered according to their tissue of origin.
Style APA, Harvard, Vancouver, ISO itp.
9

Hu, Yingchuan, i 胡穎川. "Molecular pathogenesis of oesophageal squamous cell carcinoma". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31241797.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Sun, Li, i 孫莉. "Molecular cytogenetics of oral squamous cell carcinoma". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B36544267.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Squamous cell carcinoma"

1

Warnakulasuriya, Saman, i Zakir Khan, red. Squamous cell Carcinoma. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Mortensen, Daniel V. Squamous cell carcinoma. Hauppauge, N.Y: Nova Science Publishers, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Lam, Alfred K., red. Esophageal Squamous Cell Carcinoma. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0377-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ando, Nobutoshi, red. Esophageal Squamous Cell Carcinoma. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4190-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ando, Nobutoshi, red. Esophageal Squamous Cell Carcinoma. Tokyo: Springer Japan, 2015. http://dx.doi.org/10.1007/978-4-431-54977-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

National Cancer Institute (U.S.), red. Skin cancers: Basal cell and squamous cell carcinomas. [Bethesda, Md.?]: National Cancer Institute, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Routray, Samapika, red. Microbes and Oral Squamous Cell Carcinoma. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0592-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Schmults, Chrysalyne D., red. High-Risk Cutaneous Squamous Cell Carcinoma. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-47081-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Keystone Symposia on Molecular and Cellular Biology (1991 Steamboat Springs, Colo.). Biology of and novel therapeutic approaches for epithelial cancers of the aerodigestive tract: Proceedings of a conference held at Steamboat Springs, Colorado, April 1-7, 1991. Bethesda, MD: National Cancer Institute, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

National Cancer Institute (U.S.), red. Biology of and novel therapeutic approaches for epithelial cancers of the aerodigestive tract: Proceedings of a conference held at Steamboat Springs, Colorado, April 1-7, 1991. Bethesda, MD: National Cancer Institute, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Squamous cell carcinoma"

1

Johnson, Newell W. "Introduction—The Biology and Pathology of Squamous Cell Carcinomata in the Head and Neck". W Squamous cell Carcinoma, 1–35. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Nagao, Toru, i Saman Warnakulasuriya. "Envoi—An Appraisal of Targeted Therapies for Head and Neck Cancer". W Squamous cell Carcinoma, 217–78. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

González Moles, Miguel Ángel. "Cancer Stem Cells—Biopathology with Reference to Head and Neck Cancers". W Squamous cell Carcinoma, 37–57. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Tavassoli, Mahvash, i Yae-eun Suh. "Hypoxia in Head and Neck Cancer". W Squamous cell Carcinoma, 59–95. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Monteiro, Luis, i Saman Warnakulasuriya. "Genetic Aberrations and Molecular Pathways in Head and Neck Cancer". W Squamous cell Carcinoma, 97–111. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Philips, Ramez, i Quintin Pan. "p53 in Head and Neck Squamous Cell Carcinoma". W Squamous cell Carcinoma, 113–34. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Schmitz, Sandra, i Jean-Pascal Machiels. "Blockage of EGFR Pathway for Anticancer Therapy in Squamous Cell Carcinoma of the Head and Neck". W Squamous cell Carcinoma, 135–61. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Amornphimoltham, Panomwat, Samuel J. Roth, Trey Ideker i J. Silvio Gutkind. "Targeting the mTOR Signaling Circuitry in Head and Neck Cancer". W Squamous cell Carcinoma, 163–81. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Khan, Zakir. "Survivin as a Therapeutic Target in Squamous Cell Carcinoma". W Squamous cell Carcinoma, 183–203. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Lambert, Daniel W., Hataitip Tasena i Paul M. Speight. "MicroRNA: Utility as Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma". W Squamous cell Carcinoma, 205–15. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-1084-6_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Squamous cell carcinoma"

1

Thakkar, V. R., A. Adial, M. Patel, P. Verma, P. Upadhyaya i P. Trivedi. "Unusual Peripheral Cavitating Squamous Cell Carcinoma". W American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5746.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Arciniegas Flores, R. A., S. Purdon, A. Wolfe, R. Rico, D. Ashkin i R. A. Alvarez. "Squamous Cell Carcinoma Causing Rasmussen Aneurysm". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6934.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Altayeb, Yousra Bashir Fathalrhman, i Ecir Yılmaz. "Oral Squamous Cell Carcinoma (OSCC) Treatment by Magneti Nanoparticles (Hyperthermia Method): A Review". W 6th International Students Science Congress. Izmir International Guest Student Association, 2022. http://dx.doi.org/10.52460/issc.2022.020.

Pełny tekst źródła
Streszczenie:
Squamous cell carcinoma (SCC) is the most commonly diagnosed oral cancer. It is a type of head and neck squamous cell carcinoma (HNSCC) oral cancer affects more than 300,000 people in a year. Oral cancer is the sixth most common malignant cancer. The traditional methods of treatment were used through surgery, followed by chemotherapy, but these methods are not effective enough for the treatment, so treatment was focused on using magnetic nanoparticles. Magnetic nanoparticles demolish only the cancer cells directly without affecting healthy cells. They can also be used to increase the effectiveness of the other treatment methods. Iron oxide nanoparticles, maghemite (Fe2O3) and magnetite (Fe3O4) are widely used in the diagnosis and treatment of cancerous diseases. Iron oxides NPs have distinctive properties as they have good biodegradability, very low toxicity, modifiability, and ease of preparation. the method of hyperthermia is one of the effective methods in the treatment of cancer. Because cancer cells show greater sensitivity to high temperature compared to normal cells.
Style APA, Harvard, Vancouver, ISO itp.
4

Barros, Luciana, Paulo Santos, Sheila Coelho, Gustavo Vieira, Nicole Scherer, Luis Pinto i Martín Bonamino. "Immune landscape in esophageal squamous cell carcinoma". W VI Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2018. http://dx.doi.org/10.35259/isi.sact.2018_27264.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Hyun, B., i S. Bullick. "An Unusual Product of Squamous Cell Carcinoma". W American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2440.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Cavalcante Neto, P. M., A. L. C. Fernandes, A. L. G. Salviano, R. D. Rosalino, V. P. M. Moraes, Y. Tsuchiyama, M. P. Barile, O. B. Silva Neto i R. Milinavicius. "Cardiac Invasion of Pulmonary Squamous Cell Carcinoma". W American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4179.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Perri, G., VG Vilas Boas, KP Siqueira i AP Campanelli. "PO-359 Macrophage polarisation and squamous cell carcinoma". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.871.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Thakkar, V. R., A. Adial, M. Patel, A. Iftikhar, P. Upadhyaya i P. Trivedi. "Aspergillosis in the Presence of Squamous Cell Carcinoma". W American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3969.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Reddi, Kiran K., Kenneth M. Anderson, Franklin Garcia-Godoy i Yanhui H. Zhang. "Abstract 176: Tetraspanins in oral squamous cell carcinoma". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-176.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Spinelli, Pasquale, Marco Dal Fante, Andrea Mancini, Renato Massetti i Emmanuele Meroni. "Photodynamic therapy in early esophageal squamous cell carcinoma". W Fifth International Photodynamic Association Biennial Meeting, redaktor Denis A. Cortese. SPIE, 1994. http://dx.doi.org/10.1117/12.203428.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Squamous cell carcinoma"

1

Drucker, Aaron, Gaelen P. Adam, Valerie Langberg, Abhilash Gazula, Bryant Smith, Farah Moustafa, Martin A. Weinstock i Thomas A. Trikalinos. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin. Agency for Healthcare Research and Quality, 2017. http://dx.doi.org/10.23970/ahrqepccer199.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Heaton, D., R. Mustafi i J. L. Schwartz. 9-{beta}-arabinofuranosyladenine preferentially sensitizes radioresistant squamous cell carcinoma cell lines to x-rays. Office of Scientific and Technical Information (OSTI), czerwiec 1992. http://dx.doi.org/10.2172/10149645.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Poindexter, Samuel E. Comparing Immunohistologic and Demographic Variables of Head and Neck Squamous Cell Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, maj 2015. http://dx.doi.org/10.21236/ad1012738.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Tasso, Camilla Olga, Analú Barros de Oliveira, Túlio Morandin Ferrisse i Janaina Habib Jorge Jorge. Association between Candida Albicans and Squamous Cell Carcinoma: A Systematic Literature Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2021. http://dx.doi.org/10.37766/inplasy2021.3.0005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Wang, Dong, XiaoJie Duan, Yuhui Zhang, Zhen Meng i Jing Wang. Traditional Chinese medicine for oral squamous cell carcinoma: A Bayesian network meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2020. http://dx.doi.org/10.37766/inplasy2020.9.0082.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Wang, Mingfei, Linfeng Zhang, Wenhao Ren, Shaoming Li, Keqian Zhi, Jingjing Zheng i Ling Gao. Diagnostic Value of CircRNAs as Potential Biomarker in Oral Squamous Cell Carcinoma: A Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, czerwiec 2021. http://dx.doi.org/10.37766/inplasy2021.6.0037.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Foulsham, Richard. Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments (SPOT): a feasibility study. National Institute for Health and Care Research (NIHR), sierpień 2022. http://dx.doi.org/10.3310/nihropenres.1115197.1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Pomella, Silvia, Ombretta Melaiu, Loredana Cifaldi, Roberto Bei, Marco Gargari, Vincenzo Campanella i Giovanni Barillari. Biomarkers identification in oral squamous cell carcinoma mi-croenvironment: A systematic review of proteomic studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, grudzień 2023. http://dx.doi.org/10.37766/inplasy2023.12.0114.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Freire, Mariana, Diana Martins, Maria Filomena Botelho i Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.

Pełny tekst źródła
Streszczenie:
Review question / Objective: This systematic review aims to provide an overview of the immunotherapy resistance mechanisms and identify potential biomarkers associated with immunotherapy response in NSCLC, as well as examine new treatment options to overcome this hurdle. Condition being studied: Lung Cancer (LC) remains one of the leading cancers worldwide. In 2020, were globally estimated 2 206 771 new cases and 1 796 144 deaths, representing the uttermost frequent cause of cancer death. LC is classified histologically into small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), being the last one the most common, representing 80 to 85% of all LC. The three predominantly subtypes of NSCLC are lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC) and large cell carcinoma (LCLC). NSCLC is usually diagnosed in advanced-staged disease due to ambiguous and delayed severe symptoms.
Style APA, Harvard, Vancouver, ISO itp.
10

Dżaman, Karolina, i Katarzyna Czerwaty. Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2023. http://dx.doi.org/10.37766/inplasy2023.4.0021.

Pełny tekst źródła
Streszczenie:
Review question / Objective: This systematic review aims to identify studies investigating the membrane vesicle-based drug de-livery systems (DDS) for HNSCC and define the potential of extracellular vesicles (EVs) in the treatment of this disease according to the current state of knowledge. Condition being studied: Head and neck squamous cell carcinoma (HNSCC), which is ranked the sixth most common malignancy worldwide, originates in the epithelium of the oral and nasal cavities, pharynx, and larynx. The treatment of HNSCC remains a challenge and requires the involvement of a multidisciplinary team. Currently available methods of treatment, such as surgery, radiotherapy, and chemotherapy, cause significant dysfunctions and toxicity, which highlights the necessity to explore new therapeutic options. One-third of patients treated with intended curative surgery and adjuvant therapy experience local or regional recurrence and/or distant metastasis.
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Squamous cell carcinoma” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii